Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy. (Q46416585)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q48282150)
(Q56167780)
(Q51322110)
(Q48282168)
(P304) 2012-2014
(P407) (Q1860)
(P433) 10
(P478) 49
(P577) Wednesday, October 1, 2008
(P921) (Q422252)
(Q29496)
(Q7201765)
(Q18936)
(P1433) (Q6534493)
(P1476) "Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy" (language: en)
(P2093) Chadi Al-Nawakil
Edward Bourry
Christian Roux
Sophie Park
Sylvain Choquet
François Dreyfus
(P2860) (Q37486780)
(Q46847841)
(Q34549410)
(Q34134838)
(Q37023189)
(Q34632925)
(Q21092375)
(Q34426066)
other details
description scientific article

External Links